Glenmark Pharmaceuticals Ltd NSE/BSE Share

Q: How to Buy Glenmark Pharmaceuticals Ltd Stock?

<div> Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders. <div> 1. Login to the Kuvera app or website and go to Invest section. </div> <div> 2. Select stocks and search for Glenmark Pharmaceuticals Ltd or scroll over to Glenmark Pharmaceuticals Ltd </div> <div> 3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction. </div> </div>

Q: What is the Share Price of Glenmark Pharmaceuticals Ltd?

<div>The share price of Glenmark Pharmaceuticals Ltd stocks is ₹1,361.40 as on 27/04/2025</div>

Q: What is the Market Cap of Glenmark Pharmaceuticals Ltd?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Glenmark Pharmaceuticals Ltd stock is ₹38,418.8 Cr on 27/04/2025.</div>

Q: In which sector / industry does Glenmark Pharmaceuticals Ltd operate?

<div>Glenmark Pharmaceuticals Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.</div>

Q: What was the revenue of Glenmark Pharmaceuticals Ltd?

<div>The revenue of Glenmark Pharmaceuticals Ltd as of 2023 was ₹11,635.5 Cr</div>

Q: What is the PE ratio of Glenmark Pharmaceuticals Ltd?

<div>The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. P/E ratio of Glenmark Pharmaceuticals Ltd is -191.75 as on 27/04/2025.</div>

Q: What is the 52 week high price of Glenmark Pharmaceuticals Ltd?

<div> The 52 week high of Glenmark Pharmaceuticals Ltd stock is ₹1,830.05. </div>

Q: What is the 52 week low price of Glenmark Pharmaceuticals Ltd?

<div> The 52 week low of Glenmark Pharmaceuticals Ltd stock is ₹985.60. </div>

Q: Can fractional shares of Glenmark Pharmaceuticals Ltd be purchased?

<div>No, you cannot buy fractional shares of Glenmark Pharmaceuticals Ltd, or any listed Indian company as of now.</div>

Healthcare Drug Manufacturers - Specialty & Generic

₹1,361.40

-60.45

(25 Apr)

-4.3%

Loading chart

Price

₹1,361.40

Today’s high

₹1,432.00

Today’s low

₹1,355.00

52W high

₹1,830.05

52W low

₹985.60

27.1%

-191.75

4.55

EPS (TTM)

-53.22

Dividend yield

0.2%

31.8%

Market cap

₹38,418.8 Cr

Volume

17,519

Average volume

35,824

Insights

GLENMARK price is below its 200 day moving average

GLENMARK PE is in the low end of its range over the past 2 years

GLENMARK PE is in the lowest 10% across all stocks. The market is valuing it as a value stock on an earnings basis.

GLENMARK has negative earnings and hence the PE is not defined

In beta. Send feedback here.

Compare with other stock

₹6,009.20

₹2,019.10

₹1,361.40

₹1,786.85

₹1,214.70

₹1,171.10

-3.3%

-4.1%

-4.3%

-1.0%

-3.4%

-2.5%

+57.5%

+27.8%

+27.1%

+20.2%

+12.1%

-1.6%

77.19

32.20

-191.75

37.46

20.31

18.20

11.63

5.89

4.55

6.20

2.28

3.07

77.85

62.70

-7.10

47.70

59.81

64.34

Large

Financials

Income statement

Balance sheet

Cash flow

Quarterly

Annual

As of 2023

Revenue

₹11,635.5 Cr

Net income

- ₹1,501.7 Cr

See stock holdings

Top institutional holders

HDFC Asset Management Co Ltd

4.25%

Capital Research and Management Company

3.60%

Mirae Asset Global Inv (India) Pvt. Ltd

3.28%

HDFC Asset Management Company Limited

2.34%

Templeton Asset Management Ltd.

1.88%

Top mutual fund holders

HSBC Pooled Asia Pac ex Jpn Eq Idx TrkFd

3.53%

American Funds SMALLCAP World Fund

3.21%

HDFC Mid-Cap Opportunities

3.11%

Mirae Asset Large & Midcap Fund

1.17%

HSBC GIF Asia ex Japan Equity

1.04%

About Glenmark Pharma

Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe, and the rest of the world.

Company address

B. D. Sawant Marg, Glenmark House, Mumbai, MH, 400099

Company URL

https://www.glenmarkpharma.com

Key executives

Name

Title

Age

Mr. Glenn Saldanha

CEO/Chairman of the Board/Director/Managing Director

Mr. V. S. Mani

CFO/Director

Ms. Cherylann Pinto

Director/Other Corporate Officer

FAQs

How to Buy Glenmark Pharmaceuticals Ltd Stock?

What is the Share Price of Glenmark Pharmaceuticals Ltd?

What is the Market Cap of Glenmark Pharmaceuticals Ltd?

In which sector / industry does Glenmark Pharmaceuticals Ltd operate?

What was the revenue of Glenmark Pharmaceuticals Ltd?

What is the PE ratio of Glenmark Pharmaceuticals Ltd?

What is the 52 week high price of Glenmark Pharmaceuticals Ltd?

What is the 52 week low price of Glenmark Pharmaceuticals Ltd?

Can fractional shares of Glenmark Pharmaceuticals Ltd be purchased?